Ifabotuzumab Phase 1 Results

Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment

EphA3 Publication in 'Cancers'

Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth